Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • For Training Programs
  • Authors
  • Editorial Policy
  • Editorial Board
  • Content Methodology
  • Advertising Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Back to CIM Cases
OncologyMetabolic Bone Disease

Fibrous Dysplasia - McCune-Albright Syndrome

Oncology
Intermediate
6 min
High Yield
fibrous dysplasiaMcCune-Albright syndromeGNAS mutationshepherd's crook deformityground-glass appearanceprecocious pubertybisphosphonatesmalignant transformation
6:00
Start the timer to simulate exam conditions

CIM Case: Fibrous Dysplasia - McCune-Albright Syndrome

Clinical Scenario

Patient: 15-year-old female Presentation: Bilateral hip pain and progressive waddling gait over 2 years, worsening with activity Relevant history: Reached menarche at age 8 (precocious puberty), multiple café-au-lait spots noticed since infancy, previous pathological fracture of left femur at age 10, no family history Examination findings:

  • Multiple cafĂ©-au-lait spots with irregular "coast of Maine" borders
  • Bilateral coxa vara deformity with limited hip internal rotation
  • Shortened limbs (5cm LLD, left shorter)
  • Waddling gait with positive Trendelenburg bilaterally
  • Tenderness over proximal femora
  • No lymphadenopathy or masses
  • Thyroid not enlarged
  • Tanner stage 5 (early development)

Investigations Provided

Laboratory Results

TestResultNormal RangeInterpretation
Haemoglobin128 g/L115-145Normal
WCC6.8 x 10âč/L4-11Normal
Calcium2.35 mmol/L2.15-2.55Normal
Phosphate0.65 mmol/L0.8-1.5LOW
ALP420 U/L40-150Elevated
PTH4.5 pmol/L1.5-6.5Normal
25-OH Vitamin D75 nmol/L>50Normal
TSH0.3 mU/L0.4-4.0Low-normal
Free T422 pmol/L10-20High-normal
IGF-1450 ng/mL200-600Normal
FGF23180 RU/mL<100Elevated

Imaging

Image 1: Pelvis and Bilateral Hip X-rays

Radiological features:

  • Bilateral "shepherd's crook" deformity of proximal femora
  • Coxa vara (neck-shaft angle 90° bilaterally)
  • Ground-glass matrix throughout proximal femora
  • Expansile lesions with smooth endosteal scalloping
  • Previous healed fracture left femoral shaft with varus malunion
  • Acetabula appear involved
  • No aggressive periosteal reaction

Image 2: Whole Body Bone Scan

Findings:

  • Increased uptake in bilateral proximal femora
  • Increased uptake in skull base, left humerus, multiple ribs
  • Pattern consistent with polyostotic fibrous dysplasia

Image 3: CT Skull

Findings:

  • Extensive fibrous dysplasia of skull base
  • Sphenoid bone involvement
  • No optic canal encroachment currently
  • Ground-glass appearance typical

Questions & Model Answers

Q1

What is the diagnosis and what endocrine abnormalities may be present?

Q2

How do you manage the shepherd's crook deformity?

Q3

What is the risk of malignant transformation?

Q4

What are the imaging characteristics of fibrous dysplasia?

Q5

What is the histopathology and how does it differ from other lesions?

Q6

How would you manage skull base involvement and what are the ophthalmological concerns?


Key Teaching Points

Pattern Recognition

This pattern suggests McCune-Albright Syndrome:

  • Polyostotic fibrous dysplasia
  • CafĂ©-au-lait spots with "coast of Maine" borders
  • Precocious puberty (especially in females)
  • Endocrine abnormalities
  • Ground-glass appearance on X-ray
  • Shepherd's crook deformity

Distinguish from Other Conditions:

FeatureMcCune-AlbrightNeurofibromatosisMonostotic FD
Café-au-lait bordersIrregular (Maine)Smooth (California)None
Bone lesionsPolyostoticRare osseousSingle
EndocrineCommonNoNo
InheritanceSomatic mosaicAutosomal dominantSporadic

Critical Management Points

  1. Coast of Maine (irregular) borders - distinguishes from NF1
  2. Screen for multiple endocrinopathies - thyroid, GH, adrenal
  3. Hypophosphataemia is FGF23-mediated - treat with phosphate + calcitriol
  4. Bisphosphonates reduce pain - but don't prevent deformity
  5. Use IM nails, not plates - plates create stress risers
  6. Malignant transformation risk is 4-6% - radiation is contraindicated
  7. Optic nerve surveillance - essential in craniofacial involvement

Common Examiner Follow-ups

Q: "What is the role of burosumab in McCune-Albright syndrome?"

Burosumab is an anti-FGF23 monoclonal antibody:

  • Approved for X-linked hypophosphataemia
  • Being studied in FD/MAS-related hypophosphataemia
  • Normalises phosphate without high-dose supplements
  • May improve bone mineralisation
  • Currently off-label for MAS
  • Emerging evidence is promising

Q: "What is the Mazabraud syndrome?"

Mazabraud syndrome is the association of:

  • Fibrous dysplasia (usually polyostotic)
  • Intramuscular myxomas (soft tissue masses)
  • Rare, <100 cases reported
  • Myxomas are benign but can be mistaken for malignancy
  • Same GNAS mutation as McCune-Albright
  • No endocrine abnormalities

Q: "When would you biopsy a fibrous dysplasia lesion?"

Biopsy indications:

  • Atypical imaging features
  • Suspicion of malignant transformation
  • Diagnostic uncertainty
  • New pain in established lesion
  • Aggressive periosteal reaction
  • Soft tissue mass

Routine biopsy of classic-appearing FD is NOT required.


Related Topics

  • Monostotic Fibrous Dysplasia
  • Bone Tumours in Children
  • Pathological Fractures
  • Hypophosphataemic Rickets
  • Paediatric Endocrinology
  • Craniofacial Surgery
Quick Stats
Category
Oncology
DifficultyIntermediate
Time Allowed6 min
Reading Time37 min
Investigation Types
imagingbloodshistology
Exam Tips

Read the clinical scenario carefully

Structure your answers systematically

Consider differential diagnoses

Justify your investigation choices

Think about management priorities